Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer

被引：1
作者：
Havard, Robert [1 ]
Henry, N. Lynn [1 ]
机构：
[1] Univ Utah, Dept Internal Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 28期
关键词：
21 gene recurrence score; 70 gene signature; breast cancer; chemotherapy; multiparameter genomic assays; prediction; prognosis; ADJUVANT SYSTEMIC THERAPY; AMERICAN SOCIETY; GENE-EXPRESSION; GUIDE DECISIONS; WOMEN; VALIDATION; SIGNATURE; BIOMARKERS; ASSAY;
D O I：
10.2217/fon-2017-0452
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2507 / 2510
页数：4
相关论文
共 50 条
[31]   Mapping the Decision-Making Process for Adjuvant Endocrine Therapy for Breast Cancer: The Role of Decisional Resolve [J].
Beryl, Louise L. ;
Rendle, Katharine A. S. ;
Halley, Meghan C. ;
Gillespie, Katherine A. ;
May, Suepattra G. ;
Glover, Jennifer ;
Yu, Peter ;
Chattopadhyay, Runi ;
Frosch, Dominick L. .
MEDICAL DECISION MAKING, 2017, 37 (01) :79-90
[32]   A Decision-Making Tool for Early Detection of Breast Cancer on Mammographic Images [J].
Celik Ertugrul, Duygu ;
Ahmed Abdullah, Soona .
TEHNICKI VJESNIK-TECHNICAL GAZETTE, 2022, 29 (05) :1528-1536
[33]   Decision Making about Surgery for Early-Stage Breast Cancer [J].
Lee, Clara N. ;
Chang, Yuchiao ;
Adimorah, Nesochi ;
Belkora, Jeff K. ;
Moy, Beverly ;
Partridge, Ann H. ;
Ollila, David W. ;
Sepucha, Karen R. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 214 (01) :1-10
[34]   Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer [J].
Caruana, Emmanuel ;
Foucher, Yohann ;
Tessier, Philippe ;
Frenel, Jean-Sebastien ;
Classe, Jean-Marc ;
Dantan, Etienne .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) :537-542
[35]   A national study of breast and colorectal cancer patients' decision-making for novel personalized medicine genomic diagnostics [J].
Issa, Amalia M. ;
Tufail, Waqas ;
Atehortua, Nelson ;
McKeever, John .
PERSONALIZED MEDICINE, 2013, 10 (03) :245-256
[36]   Patient participation in medical decision-making:: A French study in adjuvant radio-chemotherapy for early breast cancer [J].
Protière, C ;
Viens, P ;
Genre, D ;
Cowen, D ;
Camerlo, J ;
Gravis, G ;
Alzieu, C ;
Bertucci, F ;
Resbeut, M ;
Maraninchi, D ;
Moatti, JP .
ANNALS OF ONCOLOGY, 2000, 11 (01) :39-45
[37]   Risk stratification in early breast cancer in premenopausal and postmenopausal women: integrating genomic assays with clinicopathological features [J].
Sestak, Ivana .
CURRENT OPINION IN ONCOLOGY, 2019, 31 (01) :29-34
[38]   Decision-making under clinical uncertainty: An in-depth examination of provider perspectives on adjuvant chemotherapy for stage II colon cancer [J].
Shelton, Rachel C. ;
Brotzman, Laura E. ;
Crookes, Danielle M. ;
Robles, Patrick ;
Neugut, AIfred I. .
PATIENT EDUCATION AND COUNSELING, 2019, 102 (02) :284-290
[39]   Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer [J].
Reed, Shelby D. ;
Dinan, Michaela A. ;
Schulman, Kevin A. ;
Lyman, Gary H. .
GENETICS IN MEDICINE, 2013, 15 (03) :203-211
[40]   Patient Preferences Influencing Treatment Decision-Making in Early-Stage Breast Cancer in Germany, Italy, and Japan [J].
Flood, Emuella ;
McCutcheon, Susan ;
Beusterien, Kathleen ;
Mackie, deMauri S. ;
Mokiou, Stella ;
Guillaume, Xavier ;
Mulvihill, Emily .
PATIENT PREFERENCE AND ADHERENCE, 2024, 18 :1517-1530
12345